Chronic Telogen Effluvium in a 76-Year-Old Woman Following AFib Episode and Mounjaro Therapy

Telogen effluvium (TE) is one of the most common causes of diffuse hair shedding, particularly in older adults who may experience fluctuating health conditions or medication changes. At Reena Jogi MD in Katy and Houston, Texas, we frequently evaluate patients with persistent shedding to determine underlying triggers and build personalized treatment strategies.

This case presents a 76-year-old woman with chronic hair shedding following an episode of atrial fibrillation and while taking Mounjaro for diabetes—both potential contributors to TE.

Patient Background

The patient is a 76-year-old female, established with the clinic, presenting with 8 months of diffuse hair loss. She described the shedding as:

  • Moderate in severity

  • Gradual in onset

  • Diffuse across the scalp

Current Treatments

She has been using:

  • Ethica topical for 1 month (recommended by hairdresser)

Relevant Medical History

  • Atrial fibrillation (AFib) episode prior to onset of shedding

  • Currently taking Mounjaro, a medication known to cause or worsen hair shedding in some individuals

Clinical Examination

A full examination included inspection of:

  • Scalp and hair with dermatoscopy

  • Head and face

Findings

  • Well-developed, well-nourished

  • Alert, oriented ×3

  • No acute distress

  • Diffuse hair shedding

  • Positive hair pull test, especially notable on the left superior parietal scalp

  • No scarring or inflammation noted

These findings are most consistent with chronic telogen effluvium.

Diagnosis: Chronic Telogen Effluvium

The timing of symptoms supports TE triggered by:

  • Recent AFib episode (physiologic stress)

  • Mounjaro, which is associated with increased shedding in some patients

  • Age-related changes in follicular cycling

Because TE persists when the underlying trigger is chronic or unresolved, this presentation aligns with chronic TE.

A punch biopsy was recommended to further confirm the diagnosis if needed.

Treatment Discussion & Counseling

A comprehensive discussion covered all major treatment options, including risks, benefits, and expected outcomes.

Reviewed Treatment Options

  • Topical 5% minoxidil solution

  • Oral minoxidil (pending cardiology clearance due to AFib)

  • Spironolactone

  • Finasteride / dutasteride

  • Low-level laser therapy (Theradome, laser caps)

  • Nutritional supplements (Nutrafol, Viviscal)

  • PRP therapy vs. AlmaTED

Because TE is shedding—not scarring—the goal is to stabilize the hair cycle and support regrowth.

Medications Selected

✔ Dutasteride 0.5 mg Daily

The patient elected to begin dutasteride, with full counseling provided.

Dutasteride Counseling Included:

  • Possible side effects:

    • Breast tenderness

    • Low libido

    • Mood changes

    • Depression

  • Medication is teratogenic

  • Importance of adherence and consistent daily use

✔ Ask Cardiologist About Oral Minoxidil

Given her AFib history, consultation with her cardiologist is required before considering oral minoxidil due to potential cardiovascular effects.

✔ Continue Topical Minoxidil 5%

Recommended as a safe and effective option for chronic TE.

General Counseling Provided

Education on Telogen Effluvium

  • TE is a hair-shedding condition caused by physiologic stress, illness, medication changes, or metabolic shifts

  • Most cases resolve within several months, but chronic triggers may prolong shedding

  • Treatment focuses on supporting follicle recovery while triggers stabilize

When to Contact the Office

  • Worsening shedding

  • Lack of improvement with treatment

  • New symptoms or medication side effects

A TE handout was given for home review.

Follow-Up Plan

The patient will return in 6 months for reevaluation of shedding, density, and response to dutasteride. If shedding persists, additional interventions such as PRP or low-level laser therapy may be considered.

Conclusion

This case illustrates the complexity of chronic telogen effluvium in older adults, especially when medical conditions and medications play a role. With proper evaluation, patient education, and a tailored treatment plan—including cautious introduction of medications like dutasteride—patients can achieve stabilization and improved hair density over time.

At Reena Jogi MD in Katy & Houston, Texas, we specialize in diagnosing and managing both chronic and acute hair loss, ensuring each patient receives individualized care at every stage of their health journey.

Previous
Previous

Sudden Hair Shedding and Folliculitis in a 24-Year-Old Male: Understanding Telogen Effluvium and Early Hair Loss Treatment Options

Next
Next

17-Year-Old Female with Hormonal, Cystic Acne – Follow-Up Evaluation